Lufthansa Group will take a 10% stake in airBaltic, in the form of convertible shares, for EUR14 million and a supervisory board seat. Subject to competition authority approval, the deal is expected ...

IPOBIOVERSYS SUCCESSFULLY COMPLETES ITS IPO AT CHF 36 PER SHARE AND STARTS TRADING ON THE SIX SWISS EXCHANGE TOMORROW, FEBRUARY 07, 2025 06.02.2025 / 07:00 CET/CEST__________THIS IS A RESTRICTED ...

R. F. Lafferty & Co., Inc. acted as exclusive placement agent for the offerings. Hunter Taubman Fischer & Li LLC acted as counsel to the Company. Lucosky Brookman LLP acted as counsel to R. F.

For more information, please visit ipo.derayah.com ...

On January 29, Nasdaq reported its fourth quarter and full year 2024 earnings. Nasdaq’s results reflected a year of strong financial and operational performance as well as strategic execution across ...

Ares Management Corporation ( NYSE: ARES) Q4 2024 Earnings Conference Call February 5, 2025 10:00 AM ET Greg Mason - Co-Head-Public Markets IR Michael Arougheti - CEO Jarrod Phillips - CFO Blair ...

Flowco Holdings Inc. recently completed its initial public offering (IPO) of shares of Class A common stock at a price of $24.00 per share. This offering, which closed on January 17, 2025, saw the ...

Taking a company public is one of the most significant milestones in its journey – a moment where vision meets valuation and ...

R. F. Lafferty & Co., Inc. is acting as exclusive placement agent for the offerings. Hunter Taubman Fischer & Li LLC is acting as counsel to the Company. Lucosky Brookman LLP is acting as counsel to R ...

The company successfully raised $9.2 million in gross proceeds through the exercise of the over-allotment option in its IPO, enhancing its financial resources for growth and operations. The full ...

CTRL Group Limited (the “Company”) (NasdaqCM: MCTR), an integrated marketing and advertising services provider in Hong Kong specializing in mobile games promotion for the local market, today announced ...

Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...